Decitabine
Drug Safety
Jianxiang WangSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Drug Safety cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ceftaroline Keith A. Rodvold | Phase 1 | CC |
Anti-Grp78 Monoclonal Igm Antibody Pat-Sm6 Patrys Ltd. | Phase 1 | NR |
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →